Pharma & Bio

Latest News


Pfizer cuts neuroscience research into Alzheimer's and Parkinson's diseases

Drug giant Pfizer’s announcement that it will withdraw from neuroscience research into products aimed at treating Alzheimer’s and Parkinson’s disease has been greeted with dismay by charities.

Industry Update

Editor's comment

Pills drugs medicine

Editor’s Comment: Modern medicine

We are fortunate in the UK. For many illnesses, you need only head to your local pharmacy and hey presto: they have a medicine for your ailment.

Comment & Features

Industry 4.0: the antidote to supply chain disruption

Industry 4.0 and smart use of data is not disrupting the supply chain, says LLamasoft’s Michael Wallraven. In fact it could be the antidote to such problems.


Dust explosion short course at the Wolfson Centre

New hazards: COMAH 2015

The introduction of new COMAH regulations will see many smaller firms affected by the rules for the first time.